These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 336110

  • 1. Clinical and polygraphic effects of d.1 5 HTP on narcolepsy-cataplexy.
    Autret A, Minz M, Beillevaire T, Degos C, Cathala HP.
    Biomedicine; 1977 Jul; 27(5):200-3. PubMed ID: 336110
    [Abstract] [Full Text] [Related]

  • 2. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 3. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
    Broughton R, Mamelak M.
    Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
    [Abstract] [Full Text] [Related]

  • 4. The influence of imipramine, dexphenmetrazine and amphetaminsulphate upon the clinical and polygraphic picture of narcolepsy-cataplexy.
    Roth B, Faber J, Nevsímalová S, Tosovský J.
    Schweiz Arch Neurol Neurochir Psychiatr; 1971 Feb; 108(2):251-60. PubMed ID: 4330752
    [No Abstract] [Full Text] [Related]

  • 5. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.
    U.S. Xyrem Multicenter Study Group.
    Sleep Med; 2004 Mar; 5(2):119-23. PubMed ID: 15033130
    [Abstract] [Full Text] [Related]

  • 6. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ.
    Rev Neurol; 2004 Mar; 48(1):27-31. PubMed ID: 19145563
    [Abstract] [Full Text] [Related]

  • 7. Ritanserin improves sleep quality in narcolepsy.
    Mayer G.
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [Abstract] [Full Text] [Related]

  • 8. [Effect of imipramine, dexphenmetrazine and amphetamine sulfate on synchronous and paradoxical sleep in narcolepsy-cataplexy. A polygraphic study].
    Roth B, Faber J, Nevsímalová S, Tosovský J.
    Cesk Neurol; 1970 Jan; 33(1):29-35. PubMed ID: 4312702
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of essential headache in developmental age with L-5-HTP (cross over double-blind study versus placebo)].
    Longo G, Rudoi I, Iannuccelli M, Strinati R, Panizon F.
    Pediatr Med Chir; 1984 Jan; 6(2):241-5. PubMed ID: 6397729
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
    Mattarozzi K, Bellucci C, Campi C, Cipolli C, Ferri R, Franceschini C, Mazzetti M, Russo PM, Vandi S, Vignatelli L, Plazzi G.
    Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
    [Abstract] [Full Text] [Related]

  • 12. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
    Scharf MB, Brown D, Woods M, Brown L, Hirschowitz J.
    J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 14. Narcolepsy. Diagnosis and treatment.
    Dement WC, Carskadon MA, Guilleminault C, Zarcone VP.
    Prim Care; 1976 Dec 01; 3(4):609-23. PubMed ID: 1051517
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
    Shelton J, Nishino S, Vaught J, Dement WC, Mignot E.
    Sleep; 1995 Dec 01; 18(10):817-26. PubMed ID: 8746387
    [Abstract] [Full Text] [Related]

  • 16. Narcolepsy in seven dogs.
    Mitler MM, Soave O, Dement WC.
    J Am Vet Med Assoc; 1976 Jun 01; 168(11):1036-8. PubMed ID: 945254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep 01; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.
    Scrima L, Hartman PG, Johnson FH, Hiller FC.
    Biol Psychiatry; 1989 Aug 01; 26(4):331-43. PubMed ID: 2669980
    [Abstract] [Full Text] [Related]

  • 20. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group.
    Sleep Med; 2005 Sep 01; 6(5):415-21. PubMed ID: 16099718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.